Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Inwards

Showing results (121-130 of 179) with videos related to

Pageof 18
Sort By:
Blood Cancer Journal|May 3, 2022
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohortsSanjal H Desai, Levi Pederson, Betsy LaPlant, et al.
American Journal of Hematology|September 18, 2014
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphomaThomas E Witzig, Matthew J Maurer, Thomas M Habermann, et al.
Hematological Oncology|August 28, 2021
Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg typeRobert M Kraft, Stephen M Ansell, Jose C Villasboas, et al.
Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
American Journal of Hematology|February 4, 2021
Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosisGaurav Goyal, Jithma P Abeykoon, Marie Hu, et al.
Blood Advances|October 18, 2021
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomesAlessia Castellino, Yucai Wang, Melissa C Larson, et al.
Blood Cancer Journal|November 13, 2023
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort studyAllison M Bock, Jennifer J Gile, Melissa C Larson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphomaMatthew T Drake, Matthew J Maurer, Brian K Link, et al.
American Journal of Hematology|February 18, 2017
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphomaN Nora Bennani, Betsy R LaPlant, Stephen M Ansell, et al.
European Journal of Haematology|January 29, 2008
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeAngela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, et al.
Pageof 18

Showing results (121-130 of 179) with videos related to

Sort By:
Pageof 18
Blood Cancer Journal|May 3, 2022
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohortsSanjal H Desai, Levi Pederson, Betsy LaPlant, et al.
American Journal of Hematology|September 18, 2014
Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphomaThomas E Witzig, Matthew J Maurer, Thomas M Habermann, et al.
Hematological Oncology|August 28, 2021
Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg typeRobert M Kraft, Stephen M Ansell, Jose C Villasboas, et al.
Leukemia & Lymphoma|November 30, 2012
A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulinJeremy T Larsen, William J Hogan, Ivana N Micallef, et al.
American Journal of Hematology|February 4, 2021
Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosisGaurav Goyal, Jithma P Abeykoon, Marie Hu, et al.
Blood Advances|October 18, 2021
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomesAlessia Castellino, Yucai Wang, Melissa C Larson, et al.
Blood Cancer Journal|November 13, 2023
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort studyAllison M Bock, Jennifer J Gile, Melissa C Larson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Vitamin D insufficiency and prognosis in non-Hodgkin's lymphomaMatthew T Drake, Matthew J Maurer, Brian K Link, et al.
American Journal of Hematology|February 18, 2017
Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphomaN Nora Bennani, Betsy R LaPlant, Stephen M Ansell, et al.
European Journal of Haematology|January 29, 2008
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeAngela Dispenzieri, Martha Q Lacy, Suzanne R Hayman, et al.
Pageof 18